packagePexidartinib

pexidartinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pexidartinib is a protein kinase inhibitor used to treat tenosynovial giant cell tumour of the tendon sheath (pigmented villonodular synovitis). It is approved in the United States but its use is restricted, carrying a boxed warning for liver injury; a marketing application in the European Union was refused.

Summary written by glm-5.3-flash from Wikidata Q25100640 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pexidartinib
ATC codes:L01EX15, L01XE
DrugBank:DB12978
PubChem CID:25151352
ChEBI:145373
Wikidata:Q25100640
formula:C20H15ClF3N5
molar mass:417.819 g/mol (PubChem CID 25151352)
logP:4.5 (Drugs.Common 25.09, not verified)

Metabolites

ZAADZAADmolar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
ZAADmetabolite: ZAAD